<DOC>
<DOCNO>
EP-0015631
</DOCNO>
<TEXT>
<DATE>
19800917
</DATE>
<IPC-CLASSIFICATIONS>
C07D-249/12 A61P-31/00 C07D-249/00 A61K-31/545 C07D-501/36 A61K-31/546 C07D-501/00 <main>C07D-249/12</main> A61P-31/04 
</IPC-CLASSIFICATIONS>
<TITLE>
((4,5-dihydro-5-thioxo-1h-1,2,4-triazol-3-yl)thio)acetic acid and its salts.
</TITLE>
<APPLICANT>
smithkline beckman corpus<sep>smithkline beckman corporation<sep>smithkline beckman corporationp.o. box 7929 1 franklin plazaphiladelphia pennsylvania 19101us<sep>smithkline beckman corporation  <sep>
</APPLICANT>
<INVENTOR>
berges david alan<sep>berges, david alan<sep>berges, david alan18 buckwalter roadphoenixville, pennsylvania 19460us<sep>berges, david alan<sep>berges, david alan18 buckwalter roadphoenixville, pennsylvania 19460us<sep>
</INVENTOR>
<ABSTRACT>
the invention provides [(4,5-dihydro-5-thioxo-1h-­ 1,2,4-triazol-3-yl)thio]acetic acid, its alkali metal and am­ monium salts.  the compounds are useful as intermediates  in cephalosporin synthesis.  
</ABSTRACT>
</TEXT>
</DOC>
